Syndrome des anticorps antiphospholipides : Questions médicales fréquentes
Nom anglais: Antiphospholipid Syndrome
Descriptor UI:D016736
Tree Number:C20.111.197
Termes MeSH sélectionnés :
Cosmetics
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome des anticorps antiphospholipides : Questions médicales les plus fréquentes",
"headline": "Syndrome des anticorps antiphospholipides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome des anticorps antiphospholipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-12",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes",
"url": "https://questionsmedicales.fr/mesh/D001327",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes",
"code": {
"@type": "MedicalCode",
"code": "D001327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des anticorps antiphospholipides",
"alternateName": "Antiphospholipid Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D016736",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Doruk Erkan",
"url": "https://questionsmedicales.fr/author/Doruk%20Erkan",
"affiliation": {
"@type": "Organization",
"name": "Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, and Weill Cornell Medicine, New York, NY, USA."
}
},
{
"@type": "Person",
"name": "Hannah Cohen",
"url": "https://questionsmedicales.fr/author/Hannah%20Cohen",
"affiliation": {
"@type": "Organization",
"name": "Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK."
}
},
{
"@type": "Person",
"name": "Imad Uthman",
"url": "https://questionsmedicales.fr/author/Imad%20Uthman",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon."
}
},
{
"@type": "Person",
"name": "Katrien M J Devreese",
"url": "https://questionsmedicales.fr/author/Katrien%20M%20J%20Devreese",
"affiliation": {
"@type": "Organization",
"name": "Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium."
}
},
{
"@type": "Person",
"name": "Yu Zuo",
"url": "https://questionsmedicales.fr/author/Yu%20Zuo",
"affiliation": {
"@type": "Organization",
"name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Amended Safety Assessment of Persulfates as Used in Cosmetics.",
"datePublished": "2022-09-27",
"url": "https://questionsmedicales.fr/article/36165404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10915818221124299"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of Cosmetic Dispersions Based on Friction Dynamics.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35793976",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5650/jos.ess22083"
}
},
{
"@type": "ScholarlyArticle",
"name": "Safety Assessment of Carbonate Salts as Used in Cosmetics.",
"datePublished": "2022-05-08",
"url": "https://questionsmedicales.fr/article/35531773",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10915818221087202"
}
},
{
"@type": "ScholarlyArticle",
"name": "The development and application of a novel hazard scoring tool for assessing impacts of cosmetic ingredients on aquatic ecosystems: A case study of rinse-off cosmetics.",
"datePublished": "2023-04-10",
"url": "https://questionsmedicales.fr/article/36919679",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ieam.4765"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fragrance allergens in cosmetic products marketed for children in Denmark.",
"datePublished": "2023-08-17",
"url": "https://questionsmedicales.fr/article/37591237",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cod.14397"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndrome des anticorps antiphospholipides",
"item": "https://questionsmedicales.fr/mesh/D016736"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome des anticorps antiphospholipides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome des anticorps antiphospholipides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome des anticorps antiphospholipides",
"description": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe diagnostic nécessite-t-il des symptômes cliniques ?\nPeut-on avoir le syndrome sans symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Cosmetics&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les symptômes courants du syndrome ?\nLe syndrome peut-il causer des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLe syndrome affecte-t-il la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Cosmetics&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome des anticorps antiphospholipides",
"description": "Comment prévenir les complications du syndrome ?\nY a-t-il des changements de mode de vie recommandés ?\nLes femmes enceintes doivent-elles être surveillées ?\nLes vaccinations sont-elles importantes ?\nLe stress a-t-il un impact sur le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Cosmetics&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome des anticorps antiphospholipides",
"description": "Quels traitements sont disponibles pour le syndrome ?\nLes anticoagulants sont-ils efficaces ?\nLe traitement est-il à vie ?\nY a-t-il des effets secondaires aux traitements ?\nLes femmes enceintes peuvent-elles être traitées ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Cosmetics&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome des anticorps antiphospholipides",
"description": "Quelles sont les complications possibles du syndrome ?\nLe syndrome peut-il causer des problèmes cardiaques ?\nY a-t-il des risques pour la santé mentale ?\nLes complications sont-elles réversibles ?\nLe syndrome augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Cosmetics&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome des anticorps antiphospholipides",
"description": "Quels sont les facteurs de risque du syndrome ?\nLe sexe influence-t-il le risque ?\nLes antécédents de thromboses augmentent-ils le risque ?\nLes infections virales sont-elles un facteur de risque ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Cosmetics&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps antiphospholipides."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le lupus anticoagulant, les anticorps anti-cardiolipine et anti-bêta-2-glycoprotéine I."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents de thromboses et la présence d'anticorps spécifiques."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il des symptômes cliniques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de thromboses ou de complications obstétricales sont souvent requis."
}
},
{
"@type": "Question",
"name": "Peut-on avoir le syndrome sans symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent avoir des anticorps sans présenter de symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des thromboses, des fausses couches et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs peuvent survenir en raison de thromboses dans les vaisseaux sanguins."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des maux de tête, des AVC ou des troubles cognitifs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Le syndrome affecte-t-il la grossesse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des complications comme des fausses couches ou des prééclampsies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du syndrome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la prise régulière d'anticoagulants et le suivi médical."
}
},
{
"@type": "Question",
"name": "Y a-t-il des changements de mode de vie recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé, faire de l'exercice et éviter le tabac sont conseillés."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance étroite est essentielle pour prévenir les complications obstétricales."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent le syndrome."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le syndrome ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, donc des techniques de gestion du stress sont utiles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants et des médicaments immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Les anticoagulants sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints."
}
},
{
"@type": "Question",
"name": "Le traitement est-il à vie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais de nombreux patients nécessitent un traitement à long terme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles être traitées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables."
}
},
{
"@type": "Question",
"name": "Le syndrome augmente-t-il le risque de cancer ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du syndrome ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents de thromboses augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de thromboses et de complications."
}
}
]
}
]
}
The Expert Panel for Cosmetic Ingredient Safety (Panel) reassessed the safety of 3 persulfate ingredients, which function as oxidizing agents in cosmetic products. The Panel reviewed relevant data rel...
Frictional properties are one of the most important physical factors in the design of cosmetic dispersions in which solid particles are dispersed in a liquid. The effects of ingredients and formulatio...
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 6 carbonate salts which function as absorbents, bulking agents, opacifying agents, pH adjusters, buffering agents, abrasi...
The cosmetic industry has been committed to promoting less hazardous products to reduce the environmental impacts of cosmetic ingredients. This requires identifying safer cosmetic ingredients for deve...
Fragrances are among the most common contact allergens in children. Cosmetic products are the most frequent source of skin exposure....
To investigate exposure to fragrance allergens among Danish children, based on a sample of 1179 cosmetic products marketed for children....
Information regarding cosmetic products marketed to children was obtained using a non-profit smartphone application registry, with data from December 2015 to November 2022....
The number of validated products was 26 537, of which 1349 marketed for children. After elimination of duplicates, 1179 (4.4%) individual products remained. The majority 53.8% (634/1179) of the produc...
Children can be exposed to a vast number of fragrance allergens from scented cosmetic products. Allergens from FM I and FMII are widely used in cosmetic products marketed to children. Patch testing wi...
Lipopeptides are surface active, natural products of bacteria, fungi and green-blue algae origin, having diverse structures and functionalities. In analogy, a number of chemical synthesis techniques g...
The cosmetics industry is currently looking for innovative ingredients with higher bioactivity and bioavailability for the masses of natural and organic cosmetics. Bioferments are innovative ingredien...
Cosmetic facial tattoos have proven difficult to remove despite advancements in laser technology....
Review safety and efficacy of picosecond laser removal of cosmetic facial tattoos....
Retrospective chart review from January 2015 to January 2022 of patients undergoing tattoo removal of facial cosmetic tattoos....
A total of 33 patients were included in the review. The average number of treatments to obtain satisfactory results was 3. Sixty 6 percent of subjects were rated as "very much improved" with 76% to 10...
Picosecond laser is an effective and safe treatment for cosmetic tattoos, and it highlights the underreported unmasking of an orange color postlaser treatment that can be successfully treated with a 5...
The study aimed to measure the level of attitudes and the current practices of the female community in Brunei Darussalam regarding the usage of cosmetics....
An online survey was conducted using a non-probabilistic snowball sampling approach via the social media channels WhatsApp and Instagram. The inclusion criteria were female Bruneian citizens or perman...
A total of 445 participants responded to the online survey. Most of the participants agreed that the use of cosmetic products improves one's physical appearance to the public (391, 87.8%) and also imp...
There is a medium to high level of attitude and a high level of practice regarding the safe use of cosmetics among Bruneian female adults. Social media was the main source of information for the respo...
The current mindset in the cosmetics market about sustainable ingredients had increased the search for new sources of natural active ingredients. Cyanobacteria are a great source of functional ingredi...